Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oramed Pharmaceuticals (ORMP) Exchange Rate Effect (2022 - 2025)

Oramed Pharmaceuticals (ORMP) has disclosed Exchange Rate Effect for 3 consecutive years, with -$2000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Exchange Rate Effect fell 125.0% year-over-year to -$2000.0, compared with a TTM value of -$4000.0 through Dec 2024, up 92.59%, and an annual FY2024 reading of -$4000.0, up 92.59% over the prior year.
  • Exchange Rate Effect was -$2000.0 for Q4 2024 at Oramed Pharmaceuticals, down from $3000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $8000.0 in Q4 2023 and bottomed at -$105000.0 in Q4 2022.
  • Average Exchange Rate Effect over 3 years is -$16000.0, with a median of -$1500.0 recorded in 2024.
  • The sharpest move saw Exchange Rate Effect crashed 1133.33% in 2023, then skyrocketed 109.68% in 2024.
  • Year by year, Exchange Rate Effect stood at -$105000.0 in 2022, then skyrocketed by 107.62% to $8000.0 in 2023, then tumbled by 125.0% to -$2000.0 in 2024.
  • Business Quant data shows Exchange Rate Effect for ORMP at -$2000.0 in Q4 2024, $3000.0 in Q3 2024, and -$4000.0 in Q2 2024.